Table 4.
Distribution of the categorical answers for the base questions.
| Question | Value | Frequency | Question | Value | Frequency |
|---|---|---|---|---|---|
| Q1 | Yes | 284 | Q19 | Peritoneum | 9 |
| No | 47 | Ovary | 1 | ||
| Vagina | 2 | ||||
| Bladder | 3 | ||||
| Pelvic | 1 | ||||
| Prostate | 2 | ||||
| Q2 | Yes | 307 | Q22 | Yes | 2 |
| No | 23 | No | 329 | ||
| Q3 | Yes | 38 | Q24 | Transverse colon | 27 |
| No | 267 | Hepatic flexure | 9 | ||
| Cecum | 52 | ||||
| Descending colon | 12 | ||||
| Sigmoid colon | 11 | ||||
| Ascending colon | 62 | ||||
| Splenic flexure | 8 | ||||
| Q5 | Yes | 319 | Q26 | Present | 15 |
| No | 11 | Absent | 5 | ||
| Q7 | Yes | 319 | Q27 | Signet ring cell adenocarcinoma | 4 |
| No | 11 | Signet ring cell carcinoma | 2 | ||
| High grade neuroendocrine carcinoma | 1 | ||||
| Mucinous adenocarcinoma | 19 | ||||
| No residual carcinoma | 3 | ||||
| Adenocarcinoma | 306 | ||||
| Medullary carcinoma | 3 | ||||
| Squamous cell carcinoma | 1 | ||||
| Q8 | Yes | 275 | Q28 | Low | 252 |
| No | 6 | ||||
| Q10 | Positive | 1 | Q30 | Yes | 11 |
| Negative | 3 | No | 320 | ||
| Q12 | Oxaliplatin | 74 | Q32 | PT4a | 24 |
| Fluorouracil | 77 | PT4b | 21 | ||
| Leucovorin | 66 | PT3 | 157 | ||
| Cetuximab | 3 | PT1 | 43 | ||
| PT0 | 86 | ||||
| Q13 | Yes | 17 | Q33 | PN1 | 86 |
| No | 314 | PN0 | 196 | ||
| PN2 | 40 | ||||
| PNx | 9 | ||||
| Q16 | Bowel resection | 208 | Q35 | Absent | 214 |
| Local excision | 84 | Present | 117 | ||
| Biopsy | 1 | ||||
| Q17 | Laparoscopy | 52 | Q37 | Absent | 328 |
| Open approach | 237 | Present | 3 | ||